A research team led by Professor Jianwu Dai from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, in collaboration with Professor Rui Gu’s team from the China-Japan Union Hospital of Jilin University and Professor Yi Cui from the National Research Institute for Family Planning, has developed a novel therapeutic paradigm for spinal cord injury repair. By integrating the physical signaling regulation of traditional Chinese electroacupuncture with modern tissue engineering regenerative strategies, this study establishes a new treatment model that integrates complementary strategies from Eastern and Western medical practices.

A new study published in Microbiome Research Reports shows that patients with inflammatory bowel disease (IBD) can be stratified into distinct gut microbiome “cluster types” associated with differences in disease severity and progression risk. Rather than individual bacterial taxa, the study highlights community-level microbial structures as more robust indicators of disease heterogeneity. These microbiome-derived clusters were independent of traditional clinical classifications such as Crohn’s disease and ulcerative colitis, suggesting that gut ecosystem organization may offer complementary insights for disease assessment and future precision medicine.

A novel mechanism based on Sanguinarine (SAG) targeting the chaperone protein BiP to synchronously trigger apoptosis and ferroptosis in lung squamous cell carcinoma (LUSC) is provided, and a new strategy for treating this aggressive cancer via Endoplasmic Reticulum Stress (ERS) is opened.

A novel mechanism based on targeting MARK2 to destabilize mutant p53 (mutp53) and suppress triple-negative breast cancer (TNBC) progression, independent of its kinase activity, is provided, and a new strategy for treating mutTP53-driven TNBC is opened.

A new mechanism based on the natural compound chipericumin D from Hypericum monogynum to inhibit osteogenic differentiation in calcific aortic valve disease (CAVD) by directly targeting EGFR and suppressing the EGFR/PI3K/AKT signaling pathway is provided, and a new strategy for CAVD drug therapy is opened.

Researchers have discovered a new species of tiny sea slug named Thecacera sesama in Keelung, Taiwan, which measures less than three millimeters long and lives on aquatic invertebrates called bryozoans. Published in the journal ZooKeys, the discovery highlights the vast number of minute marine species that likely remain hidden due to the region's harsh and highly restricted diving conditions.